Fostamatinib Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Fostamatinib is used to treat thrombocytopenia (less than normal number of platelets) in adults with chronic immune thrombocytopenia (ITP; an ongoing condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood) who were not helped with another treatment.Fostamatinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Fostamatinib Nitroso Impurity 1 CAS NO:NA chemically represented as (6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)(nitroso)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate. Synchemia is the leading manufacturing and exporter of Fostamatinib Nitroso Impurity 1 . We supply Fostamatinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141971 |
| CAS No | NA |
| Mol.F. | C12H13N3O3S |
| Mol.Wt. | 279.31g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141972 |
| CAS No | 885-11-0 |
| Mol.F. | C11H11N3O2 |
| Mol.Wt. | 217.23 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141973 |
| CAS No | NA |
| Mol.F. | C21H40N6O12 |
| Mol.Wt. | 568.58 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141974 |
| CAS No | NA |
| Mol.F. | C22H20N8O2 |
| Mol.Wt. | 428.46 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141975 |
| CAS No | NA |
| Mol.F. | C17H17N5O2 |
| Mol.Wt. | 323.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141976 |
| CAS No | NA |
| Mol.F. | C22H42N6O14 |
| Mol.Wt. | 614.61 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141977 |
| CAS No | NA |
| Mol.F. | C23H37N3O6 |
| Mol.Wt. | 451.56 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141978 |
| CAS No | NA |
| Mol.F. | C16H18N2O5 |
| Mol.Wt. | 318.33 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141979 |
| CAS No | NA |
| Mol.F. | C30H38N2O5 |
| Mol.Wt. | 506.64 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141980 |
| CAS No | NA |
| Mol.F. | C24H32N2O4 |
| Mol.Wt. | 412.5 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141981 |
| CAS No | NA |
| Mol.F. | C10H14N2O2 |
| Mol.Wt. | 194.2 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141982 |
| CAS No | NA |
| Mol.F. | C16H22N2O3 |
| Mol.Wt. | 290.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141983 |
| CAS No | NA |
| Mol.F. | C16H22N2O2 |
| Mol.Wt. | 274.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141984 |
| CAS No | NA |
| Mol.F. | C16H24N2O2 |
| Mol.Wt. | 276.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141985 |
| CAS No | NA |
| Mol.F. | C13H10ClN3O3 |
| Mol.Wt. | 291.69 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141986 |
| CAS No | 13344-50-8 |
| Mol.F. | C5H10N2O3 |
| Mol.Wt. | 146.15 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |